Comments
Loading...
Ocular Therapeutix Earnings Estimates, EPS & Revenue | NASDAQ:OCUL | Benzinga
Ocular Therapeutix reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS Estimate
$-0.280
Quarterly Revenue Estimate
$16.95M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$63.72M
Analyze the earnings history of Ocular Therapeutix using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix | -$0.28 | -$0.28 | — | — | $14.77M | $16.95M | — | — | 05/05/2025 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.35 | -$0.22 | -$0.29 | -31.82% | $14.80M | $16.89M | $17.08M | 1.14% | 03/03/2025 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.25 | -$0.21 | -$0.22 | -4.76% | $15.08M | $17.14M | $15.43M | -10.01% | 11/14/2024 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.26 | -$0.22 | -$0.26 | -18.18% | $15.19M | $15.82M | $16.44M | 3.93% | 08/07/2024 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.39 | -$0.19 | -$0.28 | -47.37% | $13.37M | $15.41M | $14.77M | -4.13% | 05/07/2024 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.24 | -$0.30 | -$0.35 | -16.67% | $14.08M | $15.71M | $14.80M | -5.78% | 03/11/2024 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.31 | -$0.29 | -$0.25 | 13.79% | $11.96M | $15.25M | $15.08M | -1.11% | 11/07/2023 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.25 | -$0.29 | -$0.26 | 10.34% | $12.27M | $14.64M | $15.19M | 3.73% | 08/07/2023 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.22 | -$0.26 | -$0.39 | -50.00% | $13.19M | $14.10M | $13.37M | -5.15% | 05/08/2023 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.23 | -$0.25 | -$0.24 | 4.00% | $12.31M | $13.53M | $14.08M | 4.04% | 03/06/2023 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.23 | -$0.24 | -$0.31 | -29.17% | $12.15M | $14.27M | $11.96M | -16.15% | 11/07/2022 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.25 | -$0.23 | -$0.25 | -8.70% | $11.72M | $14.25M | $12.27M | -13.92% | 08/08/2022 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.24 | -$0.26 | -$0.22 | 15.38% | $7.34M | $14.20M | $13.19M | -7.13% | 05/09/2022 | Get Alert |
| OCUL | Ocular Therapeutix | -$1.21 | -$0.23 | -$0.23 | 0.00% | $7.35M | $14.44M | $12.31M | -14.76% | 02/28/2022 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.21 | -$0.26 | -$0.23 | 11.54% | $5.88M | $12.45M | $12.15M | -2.39% | 11/08/2021 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.64 | -$0.21 | -$0.25 | -19.05% | $1.57M | $11.60M | $11.72M | 1.02% | 08/09/2021 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.41 | -$0.21 | -$0.24 | -14.29% | $2.61M | $7.64M | $7.34M | -3.90% | 05/05/2021 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.54 | — | -$1.21 | — | $2.26M | $9.76M | $7.35M | -24.70% | 03/11/2021 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.45 | -$0.24 | -$0.21 | 12.50% | $829.00K | $5.49M | $5.88M | 7.03% | 11/05/2020 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.57 | -$0.31 | -$0.64 | -106.45% | $650.00K | $1.50M | $1.57M | 4.60% | 08/07/2020 | Get Alert |
| OCUL | Ocular Therapeutix | -$0.45 | -$0.37 | -$0.41 | -10.81% | $492.00K | $2.84M | $2.61M | -8.13% | 05/08/2020 | Get Alert |
Ocular Therapeutix (OCUL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.29 | $-0.22 | -31.8 % |
| Q3 | 2024-11-14 | $-0.22 | $-0.21 | -4.76 % |
| Q2 | 2024-08-07 | $-0.26 | $-0.22 | -18.2 % |
| Q1 | 2024-05-07 | $-0.28 | $-0.19 | -47.4 % |
Ocular Therapeutix (OCUL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $17.08M | $16.89M | 1.14 % |
| Q3 | 2024-11-14 | $15.43M | $17.14M | -10.0 % |
| Q2 | 2024-08-07 | $16.44M | $15.82M | 3.93 % |
| Q1 | 2024-05-07 | $14.77M | $15.41M | -4.13 % |
FAQ
When is Ocular Therapeutix (NASDAQ:OCUL) reporting earnings?
Ocular Therapeutix (OCUL) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Ocular Therapeutix (NASDAQ:OCUL)?
The Actual EPS was $-0.29, which missed the estimate of $-0.22.
What were Ocular Therapeutix’s (NASDAQ:OCUL) revenues?
The Actual Revenue was $17.1M, which beat the estimate of $16.9M.
Browse earnings estimates, EPS, and revenue on all stocks.
